Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00261612
Status:
UNKNOWN
Last Update Posted:
2006-10-18
First Post:
2005-12-01
Brief Title:
Bortezomib Rituximab and Dexamethasone BORID for RelapsedRefractory Mantle Cell Lymphoma
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-01
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-01
Completion Date Type:
None
First Submit Date:
2005-12-01
First Submit QC Date:
December 1 2005
Study First Post Date:
2005-12-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2006-10-17
Last Update Post Date:
2006-10-18
Last Update Post Date Type:
ESTIMATED